Committee header
BIOCOM CALIFORNIA PAC
Active cycles
2001-20022003-20042005-20062007-20082009-20102011-20122013-20142015-20162017-20182019-20202021-20222023-20242025-2026
Panel 2 • Finance overview
Committee finance snapshot
Scope: 2007-2008 cycle
- Raised
- $132,635Dated receipts + reported unitemized intervals
- Spent
- $136,203
- Net activity
- -$3,568
Receipt coverage evidence (42 components)
- Filing 1302889, amendment 0, A: 2007-07-01 – 2007-12-31; $1,325.00; accepted · whole interval in window
- Filing 1302889, amendment 0, F460: 2007-07-01 – 2007-12-31; amount unknown; accepted · whole interval in window
- Filing 1319312, amendment 0, F460: 2008-01-01 – 2008-03-17; amount unknown; accepted · whole interval in window
- Filing 1319312, amendment 0, C: 2008-01-01 – 2008-03-17; $0.00; accepted · whole interval in window
- Filing 1319312, amendment 0, A: 2008-01-01 – 2008-03-17; $295.00; accepted · whole interval in window
- Filing 1388725, amendment 0, F460: 2008-10-01 – 2008-12-31; amount unknown; accepted · whole interval in window
- Filing 1333220, amendment 2, A: 2008-03-18 – 2008-05-17; $115.00; accepted · whole interval in window
- Filing 1362394, amendment 1, C: 2008-07-01 – 2008-09-30; $0.00; accepted · whole interval in window
- Filing 1343139, amendment 1, C: 2008-05-18 – 2008-06-30; $0.00; accepted · whole interval in window
- Filing 1278523, amendment 1, C: 2007-01-01 – 2007-06-30; $0.00; accepted · whole interval in window
- Filing 1343139, amendment 1, A: 2008-05-18 – 2008-06-30; $120.00; accepted · whole interval in window
- Filing 1388725, amendment 0, A: 2008-10-01 – 2008-12-31; $1,065.00; accepted · whole interval in window
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 51% of dated attributable receipts.
Dominant category: Operations at 89.3% of spending.
Funding distribution
$5,000+
Count: 12
Share: 51%
Amount: $65,125
$1,000 - $4,999
Count: 12
Share: 19.4%
Amount: $24,790
$500 - $999
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageLarge-donor funded, Non-media-led spender, Active in 2007-2008 cycle.
Money over time
Dated receipts only; unitemized reporting intervals are not allocated to dates.
ContributionsExpenditures
Jan 2007Sep 2007Apr 2008Dec 2008
Count: 25
Share: 11.8%
Amount: $15,125
$100 - $499
Count: 96
Share: 17.6%
Amount: $22,508
$1 - $99
Count: 4
Share: 0.1%
Amount: $185
| Contribution bucket | Count | Amount | Share of dated receipts |
|---|
| $5,000+ | 12 | $65,125 | 51% |
| $1,000 - $4,999 | 12 | $24,790 | 19.4% |
| $500 - $999 | 25 | $15,125 | 11.8% |
| $100 - $499 | 96 | $22,508 | 17.6% |
| $1 - $99 | 4 | $185 | 0.1% |
Spending categories
Operations
Amount: $121,635
Share: 89.3%
Consulting
Amount: $10,695
Share: 7.9%
Field
Amount: $3,250
Share: 2.4%
Media
| Category | Amount | Share of spent |
|---|
| Operations | $121,635 | 89.3% |
| Consulting | $10,695 | 7.9% |
| Field | $3,250 | 2.4% |
| Media | $623 | 0.5% |
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|
| GENENTECH | $15,625 | 12.2% | 3 | Feb 15, 2008 |
| INVITROGEN | $11,000 | 8.6% | 2 | May 28, 2008 |
| AMGEN INC. | $10,000 | 7.8% | 2 | Dec 6, 2007 |
| ARENA PHARMACEUTICALS | $10,000 | 7.8% | 3 | Mar 19, 2008 |
| BIOGEN IDEC PHARMACEUTICALS CORP | $10,000 | 7.8% | 2 | Feb 21, 2008 |
| METABASIS THERAPEUTICS, INC. | $6,390 | 5% | 3 | Feb 29, 2008 |
| PFIZER, INC. | $6,000 | 4.7% | 1 | May 23, 2008 |
| PFIZER, INC. | $5,000 | 3.9% | 1 | Jan 31, 2007 |
| GEN-PROBE, INC. | $4,000 | 3.1% | 1 | Jun 2, 2008 |
| LEDFORD ENTERPRISES, INC | $3,000 | 2.3% | 2 | Jan 19, 2008 |
| SDG&E | $2,500 | 2% | 1 | May 28, 2008 |
| SEMPRA ENERGY | $2,500 | 2% | 1 | Nov 14, 2007 |
| CELGENE CORPORATION, SIGNAL RESEARCH DIVISION | $1,695 | 1.3% | 2 | Apr 25, 2008 |
| NOVACARDIA, INC. | $1,500 | 1.2% | 1 | Jun 30, 2007 |
| PHOTOTHERA | $1,500 | 1.2% | 1 | Jun 18, 2007 |
| ISIS PHARMACEUTICALS, INC. | $1,105 | 0.9% | 1 | Jan 31, 2008 |
| GERALD J YAKATAN | $1,025 | 0.8% | 3 | May 2, 2008 |
| RESPIRONICS | $1,000 | 0.8% | 1 | May 31, 2007 |
| THEODORE D ROTH | $1,000 | 0.8% | 2 | May 16, 2008 |
| DIGIRAD CORPORATION | $970 | 0.8% | 2 | Sep 30, 2008 |
| SENOMYX, INC. | $970 | 0.8% | 2 | Feb 29, 2008 |
| AMYLIN PHARMACEUTICALS | $815 | 0.6% | 1 | Feb 28, 2007 |
| DIVERSA | $815 | 0.6% | 1 | Feb 28, 2007 |
| VERENIUM CORPORATION | $815 | 0.6% | 1 | Feb 29, 2008 |
| SEQUENOM | $805 | 0.6% | 2 | Mar 19, 2008 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.